SAM
GILD icon

Silphium Asset Management’s Gilead Sciences GILD Stock Holding History

Silphium Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,000
Closed -$430K – 87
2017
Q4 		$430K Buy
+6,000
New +$456K 0.53% 31

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Silphium Asset Management's GILD Position: Q1 2018 in Review

Silphium Asset Management sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 6,000 shares — an estimated $430K sold.

Silphium Asset Management first reported a position in GILD in Q4 2017 and held it in 1 quarter. The position peaked at $430K in Q4 2017. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Silphium Asset Management reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Silphium Asset Management sold 6,000 Gilead Sciences shares in Q1 2018, an estimated $430K.
  • Silphium Asset Management first reported a position in Gilead Sciences in Q4 2017 and held it in 1 quarter.
  • Silphium Asset Management's Gilead Sciences position peaked at $430K in Q4 2017.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Silphium Asset Management's 13F filing for Q1 2018, filed 30 Jan 2025.